Abstract Nucleoside analogs (NAs) are an important class of anti-retroviral compounds used against human immunodeficiency virus (HIV). We have analyzed the potential effect of polyamines on the incorporation of NAs during DNA synthesis by HIV type-1 (HIV-1) reverse transcriptase (RT). The polyamines exert the ability to decrease the incorporation of various dideoxynucleoside triphosphates (ddATP, ddTTP or ddCTP) with both RNA/DNA and DNA/DNA substrates in the following order: spermine > spermidine > putrescine. The reduction is a sequence-independent effect, taking place at different sequence context. The results suggest that polyamines might affect the inhibition of reverse transcription by nucleoside analogs HIV-1 RT directed
Nucleoside reverse transcriptase inhibitors (NRTIs) were the first drugs used to treat human immunod...
Human immunodeficiency virus remains a serious threat for human health: over 36 million are infected...
AbstractAmong the acquired immunodeficiency syndrome (AIDS) drugs approved by the FDA for clinical u...
AbstractNucleoside analogs (NAs) are an important class of anti-retroviral compounds used against hu...
AbstractThe high error rates characteristic of human immunodeficiency virus type-1 reverse transcrip...
Human immunodeficiency virus remains a serious threat for human health: over 36 million are infected...
Reverse transcription is an important early step in retrovirus replication and is a key point target...
Human immunodeficiency virus type-1 (HIV-1) reverse transcriptase (RT) is essential for the formatio...
International audienceRNA viruses present an extraordinary threat to human health, given their sudde...
BACKGROUND: Deoxynucleoside triphosphates (dNTPs) are the normal substrates for DNA synthesis cataly...
Inhibition of reverse transcriptase (RT) is a vital tactic in the prevention of human immunodeficien...
Background: Deoxynucleoside triphosphates (dNTPs) are the normal substrates for DNA synthesis cataly...
International audienceUpon HIV-1 infection of a target cell, the viral reverse transcriptase (RT) co...
Background. The HIV-1 RT has two associated activities: i) the DNA polymerase activity (both RNA and...
HIV-1 reverse transcriptase is the key enzyme responsible for replication of the HIV-1 genome. It ac...
Nucleoside reverse transcriptase inhibitors (NRTIs) were the first drugs used to treat human immunod...
Human immunodeficiency virus remains a serious threat for human health: over 36 million are infected...
AbstractAmong the acquired immunodeficiency syndrome (AIDS) drugs approved by the FDA for clinical u...
AbstractNucleoside analogs (NAs) are an important class of anti-retroviral compounds used against hu...
AbstractThe high error rates characteristic of human immunodeficiency virus type-1 reverse transcrip...
Human immunodeficiency virus remains a serious threat for human health: over 36 million are infected...
Reverse transcription is an important early step in retrovirus replication and is a key point target...
Human immunodeficiency virus type-1 (HIV-1) reverse transcriptase (RT) is essential for the formatio...
International audienceRNA viruses present an extraordinary threat to human health, given their sudde...
BACKGROUND: Deoxynucleoside triphosphates (dNTPs) are the normal substrates for DNA synthesis cataly...
Inhibition of reverse transcriptase (RT) is a vital tactic in the prevention of human immunodeficien...
Background: Deoxynucleoside triphosphates (dNTPs) are the normal substrates for DNA synthesis cataly...
International audienceUpon HIV-1 infection of a target cell, the viral reverse transcriptase (RT) co...
Background. The HIV-1 RT has two associated activities: i) the DNA polymerase activity (both RNA and...
HIV-1 reverse transcriptase is the key enzyme responsible for replication of the HIV-1 genome. It ac...
Nucleoside reverse transcriptase inhibitors (NRTIs) were the first drugs used to treat human immunod...
Human immunodeficiency virus remains a serious threat for human health: over 36 million are infected...
AbstractAmong the acquired immunodeficiency syndrome (AIDS) drugs approved by the FDA for clinical u...